From: Relevance of biomarkers across different neurodegenerative diseases
Gene | Protein | Associated Syndrome(s) | Reference |
---|---|---|---|
APP | Amyloid precursor protein | EOAD (familial), CAA | Tanzi et al., 1987 [15] |
PSEN1 | Presenilin 1 | EOAD (familial) | Sherrington et al., 1995 [16] |
PSEN2 | Presenilin 2 | EOAD (familial) | Levy-Lahad et al., 1995 [17] |
MAPT | MAPT | bvFTD, PSP | |
C9orf72 | C9orf72 | bvFTD, ALS | Renton et al., 2011 [20] |
GRN | Progranulin | bvFTD, CBS | Gass et al., 2006 [21] |
VCP | Valosin-containing protein | ALS | Johnson et al., 2010 [22] |
TARDBP | TDP-43 | ALS | Shreedharan et al., 2008 [23] |
SOD1 | Superoxide dismutase 1 | ALS | Rosen et al., 1993 [24] |
FUS | Fused-in sarcoma | ALS | |
HTT | Huntingtin | HD | HDCRG, 1993 [27] |
SNCA | α-synuclein | PD, DLB, MSA | Kruger et al., 1998 [28] |
GBA | β-glucocerebrosidase | PD, DLB, Gaucher | Sidransky and Lopez, 2012 [29] |
PRNP | Prion protein | Prion | Liao et al., 1986 [30]; Kretzschmar et al., 1986 [31]; Hsiao et al., 1989 [32] |
ApoE (ε4 allele) | Apolioporotein-E | AD (risk factor) | |
TREM2 | TREM2 | AD (risk factor) | Guerreiro et al., 2013 [35]; Jonsson and Stafansson, 2013 [36] |